Ibex to deliver its first cancer diagnostics solution in Switzerland [Video]

Israel-based startup Ibex Medical Analytics today announced the first deployment in Switzerland of its artificial intelligence (AI) solution supporting pathologists during routine cancer diagnosis. 

Healthcare provider Kantonsspital Baselland (KSBL) will deploy the AI-powered Galen platform, helping pathologists improve accuracy and efficiency during primary cancer diagnosis.

The hospital provides histological and molecular integrative cancer diagnostics and personalised care for tumour patients.

Pathologists at KSBL will use the Galen platform to streamline workflows and improve accuracy during primary diagnosis via automated case prioritisation, cancer heatmaps, grading and other productivity-enhancing tools. 

Ibex’s Galen platform is CE marked for breast and prostate cancer detection in multiple workflows.

WHY IT MATTERS

A rise in cancer prevalence and advances in personalised medicine have resulted in growing diagnostic complexity, which significantly increases pathologists’ workloads.

As pathology labs transition towards digital solutions, pathologists can implement AI-enhanced workflows to improve quality and efficiency of cancer diagnosis, resulting in better patient care. 

THE LARGER CONTEXT

Earlier this …